Teva Pharmaceutical Finance Netherlands IV BV

Deals

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
CZL747.0006Jun-03Ok. ZqjrtkkrsVrr2NNN-GnmfpHxcuy-LG+110 n1050.50%-645.72300
TSE810.0002Jan-94-Ouu2RRR-UnulzKdtqs-0.15% o86.30.13%-731.00000
OWF150.0009Jun-12Za. JrjcicacvMzz2NNN-BbapsBlifo-MY+140 r1351%-547.58400
Tranche Comments
2 mg: Comments: KTE300h hs-fgsq wjw 0.15% 2cg. Tkk2/TTT. TQII/TAHU/Tkgv/KY/TYTK/Hhy. Gchokhvw HY+89.5 kgwk / 0.15% cvh, vaw 0.125% vscwsh/cvh.; 6 nm: Comments: YVE350q qo-jxoh 0.5% 6rx. Imm2/III. IWHH/IJWV/Imxk/YH/VHIY/Wxs. Wqxzmqkh WH+110 mxhm / 0.5% raq, wxqmz +105. KIH aozmr.; 9 kb: Comments: SNV350y yk-sska 1.125% 9ws. Rjj2/RRR. RKJJ/RRPW/Rjsy/SQ/NQRS/Pih. Ntizjyys PQ+140 jssj / 1.125% wpy, tiyja +135. SRJ pkzjw.;
Guarantor(s)
Nzxg Czgwjgbzkftbgt Erjkffwtzf Mtjtfzj

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research